Symptoms mimicking COVID-19 infection, pulmonary emboli, or septicemia delayed diagnosis of aortic bioprosthesis failure. A 71-year-old man was admitted emergently with shortness of breath, fever, cough, and chest pain. Echocardiography performed after 2 days showed diastolic regurgitation in an aortic perimount pericardial bioprosthesis implanted 12 years previously. An urgent reoperation disclosed that one pericardial cusp was torn from the stent of the valve. We have not previously encountered sudden pericardial leaflet dehiscence of an internally mounted pericardial valve that caused heart failure and found no literature report like our finding.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461114 | PMC |
http://dx.doi.org/10.1177/2050313X211048039 | DOI Listing |
Med Ultrason
December 2024
1Department of Anesthesiology, Shenzhen People's Hospital, The First Affiliated Hospital, Southern University of Science and Technology, The Second Clinical Medical College, Jinan University, Jinan, 2Department of Anesthesiology, West China Hospital, Sichuan University and The Research Units of West China, Chinese Academy of Medical Sciences, Sichuan, China.
Kyobu Geka
October 2024
Department of Cardiovascular Surgery, Ichinomiya Nishi Hospital, Ichinomiya, Japan.
The autologous pericardial aortic valve repair technique developed by Ozaki et al., using glutaraldehyde-treated autologous pericardium, has demonstrated superior durability to bioprosthetic valves. However, this technique has certain limitations, including excessive cusp height and cusp fluttering due to leaflet redunduncy.
View Article and Find Full Text PDFOper Orthop Traumatol
August 2024
Klinik für Orthopädie und Unfallchirurgie, Martin-Luther-Krankenhaus Berlin, Caspar Theyss Str. 27-33, 14193, Berlin, Deutschland.
Objective: Lengthening of the quadriceps tendon for dehiscence in chronic rupture.
Indications: Chronic rupture of the quadriceps tendon with delayed diagnosis or failure of primary refixation with a dehiscence between 1 and 5 cm.
Contraindications: Dehiscence of more than 5 cm.
Mayo Clin Proc Innov Qual Outcomes
August 2024
Department of Cardiology, Heart and Vascular Institute, Lehigh Valley Health Network, Allentown, PA.
Cureus
June 2024
Anesthesiology and Critical Care, Kindai University, Osaka, JPN.
The treatment for ischemic mitral regurgitation (MR) involves a combination of medical management and, in certain cases, surgical intervention. The approach depends on the severity of the condition, underlying causes, and the patient's overall health. A 76-year-old male with heart failure refractory to medical management because of ischemic MR was considered for a mitral valve repair surgery with a posterior mitral leaflet augmentation technique.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!